Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masahiro Fukuoka

Showing results (1-10 of 190) with videos related to

Pageof 19
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 13, 2002
[Progress in the field of pulmonary medicine in the last 100 years: Bronchoscopy]Masahiro Fukuoka
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 7, 2009
[Internal medicine specially addressed to oncology: its role in tumor care]Masahiro Fukuoka
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 7, 2002
[Progress in diagnosis and treatment of lung cancer]Masahiro Fukuoka
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 10, 2002
[Chemotherapy for lung cancer]Takayasu Kurata, Masahiro Fukuoka
Clinical Calcium|April 2, 2008
[Bone metastases in lung cancer]Asuka Tsuya, Masahiro Fukuoka
International Journal of Clinical Oncology|September 5, 2003
Molecular target-based cancer therapy: tyrosine kinase inhibitorsKenji Tamura, Masahiro Fukuoka
Expert Opinion on Pharmacotherapy|June 15, 2005
Gefitinib in non-small cell lung cancerKenji Tamura, Masahiro Fukuoka
Clinical Lung Cancer|July 28, 2009
S-1: a new oral fluoropyrimidine in the treatment of patients with advanced non-small-cell lung cancerIsamu Okamoto, Masahiro Fukuoka
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 12, 2002
[Guideline for chemotherapy of malignant lung cancer]Nobuyuki Yamamoto, Masahiro Fukuoka
Journal of the American College of Cardiology|September 11, 2007
Sex hormones as novel risk biomarkers for atherosclerosis in peripheral vascular diseasePeter P Liu, Masahiro Fukuoka
Pageof 19

Showing results (1-10 of 190) with videos related to

Sort By:
Pageof 19
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 13, 2002
[Progress in the field of pulmonary medicine in the last 100 years: Bronchoscopy]Masahiro Fukuoka
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 7, 2009
[Internal medicine specially addressed to oncology: its role in tumor care]Masahiro Fukuoka
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 7, 2002
[Progress in diagnosis and treatment of lung cancer]Masahiro Fukuoka
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 10, 2002
[Chemotherapy for lung cancer]Takayasu Kurata, Masahiro Fukuoka
Clinical Calcium|April 2, 2008
[Bone metastases in lung cancer]Asuka Tsuya, Masahiro Fukuoka
International Journal of Clinical Oncology|September 5, 2003
Molecular target-based cancer therapy: tyrosine kinase inhibitorsKenji Tamura, Masahiro Fukuoka
Expert Opinion on Pharmacotherapy|June 15, 2005
Gefitinib in non-small cell lung cancerKenji Tamura, Masahiro Fukuoka
Clinical Lung Cancer|July 28, 2009
S-1: a new oral fluoropyrimidine in the treatment of patients with advanced non-small-cell lung cancerIsamu Okamoto, Masahiro Fukuoka
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 12, 2002
[Guideline for chemotherapy of malignant lung cancer]Nobuyuki Yamamoto, Masahiro Fukuoka
Journal of the American College of Cardiology|September 11, 2007
Sex hormones as novel risk biomarkers for atherosclerosis in peripheral vascular diseasePeter P Liu, Masahiro Fukuoka
Pageof 19